Anagenics Limited (ASX:AN1)
Australia · Delayed Price · Currency is AUD 0.0060
0.00 (0.00%)
Sep 4, 2026, 11:36 AM AEST
Anagenics Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 5.16 | 5.12 | 10.8 | 9.11 | 6.95 |
| 5.16 | 5.12 | 10.8 | 9.11 | 6.95 | |
Revenue Growth | 0.80% | -52.62% | 18.54% | 31.21% | 19.41% |
Cost of Revenue | 2.16 | 2.71 | 6.44 | 4.7 | 3.15 |
Gross Profit | 3 | 2.41 | 4.36 | 4.41 | 3.8 |
Selling, General & Admin | 2.18 | 2.95 | 7.2 | 6.08 | 6.82 |
Research & Development | - | - | - | 0.02 | 0.03 |
Other Operating Expenses | 0.27 | 0.16 | 0.58 | -0.38 | -0.76 |
Operating Expenses | 2.64 | 3.36 | 8.37 | 6.16 | 6.51 |
Operating Income | 0.36 | -0.95 | -4.01 | -1.75 | -2.71 |
Interest Expense | -0.07 | -0.04 | -0.07 | -0.03 | -0.04 |
Interest & Investment Income | 0.01 | 0 | 0.02 | - | 0.02 |
Other Non Operating Income (Expenses) | - | 0.08 | 0.14 | 0.04 | 1 |
EBT Excluding Unusual Items | 0.31 | -0.9 | -3.92 | -1.73 | -1.74 |
Merger & Restructuring Charges | - | -0.63 | - | - | - |
Impairment of Goodwill | - | - | -2.74 | - | - |
Asset Writedown | - | - | -0.63 | - | - |
Other Unusual Items | - | 0.3 | - | - | 0.09 |
Pretax Income | 0.31 | -1.24 | -7.28 | -1.73 | -1.64 |
Income Tax Expense | - | - | - | 0.01 | 0 |
Earnings From Continuing Operations | 0.31 | -1.24 | -7.28 | -1.74 | -1.64 |
Earnings From Discontinued Operations | - | - | -0.21 | -0.93 | -2.01 |
Net Income | 0.31 | -1.24 | -7.49 | -2.67 | -3.65 |
Net Income to Common | 0.31 | -1.24 | -7.49 | -2.67 | -3.65 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 696 | 469 | 399 | 266 | 209 |
Shares Outstanding (Diluted) | 743 | 469 | 399 | 266 | 209 |
Shares Change | 58.29% | 17.64% | 50.02% | 27.01% | 48.30% |
EPS (Basic) | 0.00 | -0.00 | -0.02 | -0.01 | -0.02 |
EPS (Diluted) | 0.00 | -0.00 | -0.02 | -0.01 | -0.02 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -1.09 | -1.58 | -1.86 | -1.8 | -2.56 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 |
Gross Margin | 58.15% | 47.08% | 40.37% | 48.41% | 54.66% |
Operating Margin | 7.06% | -18.50% | -37.11% | -19.16% | -39.03% |
Profit Margin | 5.98% | -24.14% | -69.36% | -29.27% | -52.53% |
Free Cash Flow Margin | -21.21% | -30.79% | -17.26% | -19.80% | -36.88% |
EBITDA | 0.55 | -0.75 | -3.39 | -1.39 | -2.62 |
EBITDA Margin | 10.67% | -14.59% | -31.41% | -15.22% | -37.74% |
D&A For EBITDA | 0.19 | 0.2 | 0.62 | 0.36 | 0.09 |
EBIT | 0.36 | -0.95 | -4.01 | -1.75 | -2.71 |
EBIT Margin | 7.06% | -18.50% | -37.11% | -19.16% | -39.03% |